News
Further studies on the pathogenesis of this viral hemorrhagic fever will enhance our understanding of the mechanisms of disease and, thus, facilitate the development of the required vaccine and ...
Hosted on MSN17d
How glycoprotein GP38 from Crimean-Congo hemorrhagic fever virus could advance monoclonal antibody therapiesEvidence also shows that GP38 has a direct role in viral pathogenesis that is independent ... Antibodies targeting Crimean-Congo hemorrhagic fever virus GP38 limit vascular leak and viral spread ...
16d
News-Medical.Net on MSNGP38 identified as key viral toxin and vaccine target in Crimean-Congo hemorrhagic fever virus researchA recent study published in Science Translational Medicine involving scientists from the U.S. Army Medical Research Institute of Infectious Diseases in collaboration with scientists from the Albert ...
The U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) and medical research charity Lifearc have announced a collaboration to develop an affordable and accessible monoclonal ...
In 2022, an alert was issued due to an increase in the number of cases of Argentine hemorrhagic fever in endemic areas, “with eight infections, of which two died,” Lahitte said.
Crimean–Congo hemorrhagic fever is one of the most widely distributed ... the viral replication cycle and molecular pathogenesis, including escape strategies from the cellular innate immune ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results